The Impact of Immediate Implant Placement on Alveolar Ridge Preservation Techniques

Sponsor
Università Vita-Salute San Raffaele (Other)
Overall Status
Completed
CT.gov ID
NCT03422458
Collaborator
Osteology Foundation (Other)
30
1
3
27.3
1.1

Study Details

Study Description

Brief Summary

It is well known that following the loss of a single tooth, severe hard- and soft-tissue alterations may take place within the affected site, resulting in a subsequent reduction of both vertical and horizontal ridge dimensions, often not allowing neither appropiate pontic fabrication nor correct placement of endosseous implants.

Over the past 20 years, various surgical procedures, grouped under the term of "alveolar ridge preservation" (ARP), have been introduced, aiming to maintain the existing soft and hard tissue envelope as well as a stable ridge volume, simplifying subsequent treatment procedures and optimizing functional and esthetic outcomes. They have been widely tested in controlled and not controlled clinical studies with various materials and approaches, and a number of recently published systematic reviews on this topic have confirmed the efficacy of ARP in preventing post-extraction dimensional changes of alveolar ridges.

After these procedures a minimum of four to six months must be awaited before implant insertion can be performed, bringing the patient compromised comfort, function and aesthetics and needing of a second surgical procedure for the implant placement.

Dental implant insertion at the time of tooth extraction (type I or immediate placement) reduced the number of dental appointments, of surgeries required and the overall treatment time. Nevertheless this surgical protocol does not provide predictable outcomes, since it may contribute towards a more pronounced bone resorption during healing. Different anatomical factors, as the thickness of the buccal bone wall and the dimension of the horizontal gap, may influence the dimensional changes of the alveolar crest following immediate implant placement. Such morphological changes could lead to negative esthetic complications, such as marginal soft tissues recessions, especially when affecting the buccal side of maxillary sites in patients with a high smile line.

It is unknown if immediate implant placement plus grafting materials and/or barrier membranes could influence post-extraction dimensional changes of alveolar ridges. No consensus exists on the need for bone augmentation simultaneously with immediate implant placement. Furthermore, no human study has yet compared dimensional changes of both hard and soft tissues after two different treatments: an alveolar ridge preservation technique for a subsequent implant placement, and an alveolar ridge preservation technique with an immediate implant placement.

Condition or Disease Intervention/Treatment Phase
  • Device: Alveolar Ridge Preservation
N/A

Detailed Description

Hypothesis/Aims

Primary hypotesis

Placing an immediate implant into a fresh extraction site plus a bone substitute filling and a matrix covering could negatively modify the healing patterns and thus the tissue morphology of the ridge site with regard to:

  • clinical hard tissues dimensions (bone width and height, bone volume)

  • clinical soft tissues dimensions (soft tissues volume, keratinized tissues width and thickness, muco-gingival junction position's modifications, gingival color and texture,)

Secondary hypothesis.

Placing an immediate implant into fresh extraction site plus a bone substitute filling and a matrix covering could negatively influence tissue morphology of the preserved site with regard to:

  • clinical hard tissues dimensions (bone width and height, bone volume)

  • clinical soft tissues dimensions (soft tissues volume, keratinized tissues width and thickness, muco-gingival junction position's modifications, gingival color and texture,)

Aims:

The first aim of this study is to evaluate the possible impact on hard and soft tissue morphological changes of placing an immediate implant in post-extraction site treated by a bone substitute filling and a matrix covering.

The second aim of this study is to compare hard and soft tissue morphological changes in a spontaneous healed extraction site versus a fresh extraction site treated by immediate implant placement plus a bone substitute filling and a matrix covering

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Impact of Immediate Implant Placement on Alveolar Ridge Preservation Techniques: a Clinical, Volumetric and Radiological Randomized Controlled Clinical Trial.
Actual Study Start Date :
Jan 1, 2016
Actual Primary Completion Date :
Apr 11, 2018
Actual Study Completion Date :
Apr 11, 2018

Arms and Interventions

Arm Intervention/Treatment
No Intervention: natural healing

no treatment and the coagulum within the socket is left open for spontaneous healing

Experimental: Alveolar Ridge Preservation

A bone substitute material (BioOss Collagen) is placed within the bony envelope at least to the level of the palatal/ lingual bone plate. Subsequently, the soft tissue borders of the alveole is de-epithelialized using a diamond drill under copious irrigation with water. A collagen matrix (Mucograft Seal) is adapted to the soft tissue borders again using single interrupted sutures.

Device: Alveolar Ridge Preservation
Insertion of a bone substitute material (BioOss Collagen) within the bony envelope at least to the level of the palatal/ lingual bone plate. Adaptation of a collagen matrix (Mucograft Seal) to the soft tissue borders.

Experimental: Immediate Implant + Alveolar Ridge Preservation

An immediate implant (Winsix) placement is performed. After implant insertion, a bone substitute material (BioOss Collagen) is placed in the gap occurred between the implant surface and the hard tissue walls of the extraction socket at least to the level of the palatal/ lingual bone plate. Subsequently, the soft tissue borders of the alveole is de-epithelialized using a diamond drill under copious irrigation with water. A collagen matrix (Mugograft Seal) is adapted to the soft tissue borders again using single interrupted sutures.

Device: Alveolar Ridge Preservation
Insertion of a bone substitute material (BioOss Collagen) within the bony envelope at least to the level of the palatal/ lingual bone plate. Adaptation of a collagen matrix (Mucograft Seal) to the soft tissue borders.

Outcome Measures

Primary Outcome Measures

  1. Hard tissue volumetric changes [4 months]

    Bone volumes changes at tooth extraction site

  2. Soft tissue volumetric changes [4 months]

    Soft tissue volumes changes at tooth extraction site

Secondary Outcome Measures

  1. Keratinezed tissue (KT) [4 months]

    KT width changes at tooth extraction site

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adult patients (> 18 years old) requiring extraction (for caries, fracture, periodontitis, prosthetic reasons) and subsequent moderately rough implant-supported single crown of one upper or lower asymptomatic front tooth or premolar

  • Systemically healthy patients not smoking more than 10 cigarettes/day.

  • Oral healty patients with adequate oral hygiene (bleeding on probing < 30%; Plaque index< 30%).

Exclusion Criteria:
  • Patients smoking more than 10 cigarettes per day.

  • Patients with oral mucosa diseases

  • Patients with insulin-dependent diabetes.

  • Patients with a history of malignancy, radiotherapy, or chemotherapy for malignancy.

  • Patient pregnant or intended to be pregnant or nursing

  • Patients taking medications or having treatments with an effect on mucosal healing in general (e.g. steroids, large doses of antiinflammatory drugs).

  • Patients with a disease affecting connective tissue metabolism.

  • Patients allergic to collagen.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Università Vita-Salute San Raffaele Milano MI Italy 20132

Sponsors and Collaborators

  • Università Vita-Salute San Raffaele
  • Osteology Foundation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Marco Clementini, Research fellow, Università Vita-Salute San Raffaele
ClinicalTrials.gov Identifier:
NCT03422458
Other Study ID Numbers:
  • 14-034
First Posted:
Feb 5, 2018
Last Update Posted:
Apr 17, 2019
Last Verified:
Apr 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Apr 17, 2019